Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthstream (HSTM) Long-Term Investments (2016 - 2024)

Healthstream has reported Long-Term Investments over the past 14 years, most recently at $4.0 million for Q3 2024.

  • Quarterly Long-Term Investments fell 4.87% to $4.0 million in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $4.0 million through Sep 2024, down 4.87% year-over-year, with the annual reading at $4.1 million for FY2023, 8.5% down from the prior year.
  • Long-Term Investments was $4.0 million for Q3 2024 at Healthstream, down from $4.1 million in the prior quarter.
  • Over five years, Long-Term Investments peaked at $8.5 million in Q2 2021 and troughed at $4.0 million in Q3 2024.
  • The 5-year median for Long-Term Investments is $4.6 million (2022), against an average of $5.6 million.
  • Year-over-year, Long-Term Investments soared 79.97% in 2021 and then plummeted 44.3% in 2022.
  • A 5-year view of Long-Term Investments shows it stood at $6.8 million in 2020, then increased by 2.89% to $7.0 million in 2021, then plummeted by 35.85% to $4.5 million in 2022, then fell by 8.5% to $4.1 million in 2023, then fell by 3.63% to $4.0 million in 2024.
  • Per Business Quant, the three most recent readings for HSTM's Long-Term Investments are $4.0 million (Q3 2024), $4.1 million (Q2 2024), and $4.1 million (Q1 2024).